PHILADELPHIA (March 19, 2025) – Ten innovative health tech startups from across North America have been selected for Cohort 7 of the Science Center’s Capital Readiness Program. Spanning from California to Massachusetts and Ontario, Canada, these companies will come together in Philadelphia for the intensive five-day program from March 31 to April 4.
Designed for health tech founders pursuing their first round of institutional investment, the Capital Readiness Program provides exclusive access to prominent investors and industry stakeholders—offering rare opportunities to ask in-depth questions and gain invaluable insights that are often out of reach for founders. Over the course of a week, participants undergo a due diligence deep dive—covering financial, legal, technical, and operational considerations—while sharpening their leadership skills to scale ventures while gaining investor confidence.
"The Capital Readiness Program goes beyond simply teaching startups how to pitch to investors. We tap into our extensive network and decades of expertise to provide founders with the guidance they need to navigate the complexities of today’s funding landscape," says Tiffany Wilson, Science Center President & CEO. "Our goal isn’t just to position these companies for investment, but to equip founders with the skills and confidence needed to lead their ventures to sustainable growth and long-term impact."
Capital Readiness Program Cohort 7:
Cerespectus LLC (Philadelphia, PA)
Cerespectus™ is an early-stage medical device company that is addressing unmet clinical need of therapy delivery to the subarachnoid space by developing a minimally invasive microcatheter with camera-based navigation system for real-time anatomic visualization and targeted therapy delivery to treat neurological diseases.
Cosm Medical (Toronto, Canada)
Cosm Medical is pioneering the "Invisalign for Pelvic Health," using AI-powered software and 3D printing to create personalized gynecological prosthetics, revolutionizing care from obstetrics to surgery to elderly care.
D.Sole, Inc. (Pittsburgh, PA)
D.Sole is an AI-powered clinical decision support system that helps clinicians prevent and monitor diabetic foot complications through smart insoles with multi-parameter biosensors: improving clinician quality scores, increasing revenue, and saving payors and hospitals $13 billion annually.
ImmuNovX Biotech (Bethlehem, PA)
ImmuNovX Biotech is developing a new technology that enables a novel class of vaccines to DNA pathogens.
Liife, Inc. (Philadelphia, PA)
Liife, Inc. is a healthcare technology company focused on reducing fraud, waste, and abuse through their advanced identification verification management solution.
Lōvu Health (San Francisco, CA)
Lōvu is an augmentative AI supported digital operating system that modernizes clinical practice while connecting moms to be to all the services and tech she needs to produce her best outcome.
Mediary, Inc. (Dover, DE)
The point-of-care platform that aligns patient care and provider revenue.
UprightVR (Philadelphia, PA)
UprightVR uses virtual reality combined with neuroscience to yield the most advanced balance assessment, rehabilitation and fall prevention system in the world; their solutions are rigorously designed and validated to enhance balance for various healthcare needs, with a particular focus on improving senior care.
Venova Technologies, Inc. (Cambridge, MA)
Venova Technologies is developing a new hormone-free female birth control device designed to be highly effective, long-acting, and side-effect-free.
Wito Smart Health, Inc. (Wilmington, DE)
Wito Smart Health has engineered a wearable medical technology which utilizes a bio-impedance platform to measure key bio-markers such as blood glucose.
A key differentiator of the Capital Readiness Program is the engagement of Investors-in-Residence, who spend the week alongside founders, providing direct feedback, adding depth to insights from subject matter experts, and offering rare access to an investor’s decision-making process. Since the program was launched in 2023, the Science Center has engaged 26 Investors-in-Residence, collectively representing over $3.7 billion in venture capital across the capital stack.
Representing $1.2 billion in venture capital, Cohort 7 Investors-In-Residence include:
- Nicole Johnny, Investment Associate, Raven Indigenous Capital Partners (Albuquerque, NM)
- Lebone Moses, CEO, Chisara Ventures Inc (Durham, NC)
- Maren Nelson, Co-Chair, Life Science Screening Committee, Alliance of Angels (Seattle, WA)
- Julien Pham, Founder & Managing Partner, 3CC | Third Culture Capital (Boston, MA)
- Jake Prigoff, Partner, Gaingels (New York, NY)
The Capital Readiness Program has supported a total of 60 companies from across the U.S. that have collectively raised over $35 million. The Science Center is currently recruiting for Cohort 8 of the taking place June 23-27, 2025. Applications must be submitted by April 25th.
The program is funded in part through a Grant with the U.S. Small Business Administration and the U.S. Economic Development Administration (EDA).
About the Science Center
The Science Center is Philadelphia’s premier catalyst of entrepreneurial activity, healthcare innovation, and economic growth. Established in 1963, the nonprofit has been recognized by The Brookings Institution as a best-in-class investor, mentor, and economic development partner for young technology companies. Working alongside industry partners and leading research and academic institutions across the globe, the Science Center has supported hundreds of early-stage companies that have a combined $7.8B annual economic impact on Greater Philadelphia. Today, the organization advances healthcare innovation from idea to the marketplace through best-in-class startup acceleration activities for companies around the globe and nationally recognized STEM education curricula for Philadelphia youth. For more information, visit sciencecenter.org.
